Endocarditis, Bacterial
17
4
4
5
Key Insights
Highlights
Success Rate
56% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 77/100
23.5%
4 terminated out of 17 trials
55.6%
-31.0% vs benchmark
24%
4 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (17)
Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis
Combined Rehabilitation and Nutritional Support vs. Standard Care in In-Hospital Endocarditis Treatment
New Treatment of Cardiac Device Infections; Immediate Reimplantation After Removal of Infected System
Anemia in Patients With Endocarditis
Barts Endocarditis Research Registry
Fosfomycin I.v. for Treatment of Severely Infected Patients
Short-course Antibiotic Treatment in Gram-positive Cocci Infective Endocarditis
T2MR PCR Detection of ESKAPE Pathogens in Patients With Pyogenic Spondylodiscitis and Infective Endocarditis
Effectiveness of Antibiotic Prophylaxis of Infective Endocarditis for Invasive Dental Procedures in Patients With Prosthetic Heart Valves and/or History of Infective Endocarditis
Predictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly Staphylococcus Aureus Bacteriuria, and Time to Blood Culture Positivity
Neurological Complication of Infective Endocarditis: A Prospective Multi-site Cohort Study
Characterization of Endocarditis to Streptococci and Impact of the CMI on the Future of the Patients
Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis
Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia
Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.
How to Improve Diagnosis in Infective Endocarditis
IMAGE-Endocarditis: Resonance Magnetic Imaging at the Acute Phase of Endocarditis